Form D · Other Health Care
ViroCyt, Inc.
Boulder, CO · CIK 0001562971
Offering snapshot reported Jan 14, 2015 · SEC filing
- Reported sold
- $3.47M Offering amount: $4M
- Investors reported
- 23 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 31, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 14, 2015 | Initial | $3,467,888 | No comparison | 23 | SEC filing |
| Apr 11, 2013 | Amendment | $4,700,000 | $2,075,000vs Nov 28, 2012 | 24 | SEC filing |
| Nov 28, 2012 | Initial | $3,500,000 | No comparison | 1 | SEC filing |
| Nov 28, 2012 | Initial | $2,625,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-232188
Source: Form D, filed Jan 14, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jack Ball | Director |
| Robert Kline | Director, Executive, Promoter |
| Mark Lupa | Director |
| Dan Mitchell | Director |
| Kathy Rowlen | Director |
| Walter Young | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
2100 Central Avenue Suite 103
Boulder, CO, 80301
Boulder, CO, 80301